Back to Search
Start Over
24-h severe energy restriction impairs postprandial glycaemic control in young, lean males
- Publication Year :
- 2018
- Publisher :
- Cambridge University Press, 2018.
-
Abstract
- Intermittent energy restriction (IER) involves short periods of severe energy restriction interspersed with periods of adequate energy intake, and can induce weight loss. Insulin sensitivity is impaired by short-term, complete energy restriction, but the effects of IER are not well known. In randomised order, fourteen lean men (age: 25 (sd 4) years; BMI: 24 (sd 2) kg/m2; body fat: 17 (4) %) consumed 24-h diets providing 100 % (10 441 (sd 812) kJ; energy balance (EB)) or 25 % (2622 (sd 204) kJ; energy restriction (ER)) of estimated energy requirements, followed by an oral glucose tolerance test (OGTT; 75 g of glucose drink) after fasting overnight. Plasma/serum glucose, insulin, NEFA, glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP) and fibroblast growth factor 21 (FGF21) were assessed before and after (0 h) each 24-h dietary intervention, and throughout the 2-h OGTT. Homoeostatic model assessment of insulin resistance (HOMA2-IR) assessed the fasted response and incremental AUC (iAUC) or total AUC (tAUC) were calculated during the OGTT. At 0 h, HOMA2-IR was 23 % lower after ER compared with EB (PPPPP=0·161), GIP (P=0·473) and FGF21 (P=0·497) tAUC were similar between trials. These results demonstrate that severe energy restriction acutely impairs postprandial glycaemic control in lean men, despite reducing HOMA2-IR. Chronic intervention studies are required to elucidate the long-term effects of IER on indices of insulin sensitivity, particularly in the absence of weight loss.
- Subjects :
- Adult
Blood Glucose
Male
0301 basic medicine
medicine.medical_specialty
medicine.medical_treatment
Medicine (miscellaneous)
030209 endocrinology & metabolism
Gastric Inhibitory Polypeptide
Type 2 diabetes
Young Adult
03 medical and health sciences
0302 clinical medicine
NEFA
Insulin resistance
Glucagon-Like Peptide 1
Weight loss
Internal medicine
Weight Loss
Intermittent fasting
medicine
Humans
Insulin
Obesity
Caloric Restriction
Nutrition and Dietetics
business.industry
Fasting
Glucose Tolerance Test
Postprandial Period
medicine.disease
Glucagon-like peptide-1
Healthy Volunteers
Fibroblast Growth Factors
Glucose
030104 developmental biology
Endocrinology
Postprandial
Area Under Curve
Insulin Resistance
medicine.symptom
Energy Intake
Energy Metabolism
business
Subjects
Details
- Language :
- English
- ISSN :
- 00071145
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....8a90aecea6cfce956ef6f8b3c650b9ad